ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 34 filers reported holding ENZYMOTEC LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $94,000 | -38.6% | 13,375 | -26.9% | 0.02% | -17.9% |
| Q2 2016 | $153,000 | -30.8% | 18,301 | -44.7% | 0.03% | +47.4% |
| Q3 2014 | $221,000 | -53.1% | 33,089 | -4.8% | 0.02% | -48.6% |
| Q2 2014 | $471,000 | -7.5% | 34,744 | +50.4% | 0.04% | +8.8% |
| Q1 2014 | $509,000 | +93.5% | 23,107 | +137.3% | 0.03% | +183.3% |
| Q4 2013 | $263,000 | – | 9,736 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,143,145 | $10,323,000 | 2.59% |
| Visium Asset Management, LP | 2,200,000 | $19,866,000 | 0.34% |
| Paulson & Co. | 4,224,139 | $38,144,000 | 0.28% |
| ALGERT GLOBAL LLC | 20,988 | $190,000 | 0.07% |
| MENTA CAPITAL LLC | 43,126 | $389,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 61,844 | $558,000 | 0.04% |
| Acrospire Investment Management LLC | 2,785 | $25,000 | 0.02% |
| ICON ADVISERS INC/CO | 16,800 | $152,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 168,738 | $1,523,000 | 0.01% |
| Renaissance Technologies | 181,000 | $1,634,000 | 0.00% |